LNX1 and central nervous system cancer: Using cDNA microarray analysis, Chen et al. in 2005 [90] found that the levels of LNX1 transcript reduced significantly in human glioma specimens (collected from 18 patients), based on which they proposed that LNX1 mRNA levels would serve as a valuable diagnostic marker for glial tumors.